Phuong N. Huynh

Array ( [id] => 5040231 [patent_doc_number] => 20070092513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'ErbB4 antagonists' [patent_app_type] => utility [patent_app_number] => 11/581221 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29336 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092513.pdf [firstpage_image] =>[orig_patent_app_number] => 11581221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194381 [patent_doc_number] => 20070082865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Compositions and methods for treatment of airway hypersecretion' [patent_app_type] => utility [patent_app_number] => 11/545701 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13842 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082865.pdf [firstpage_image] =>[orig_patent_app_number] => 11545701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050877 [patent_doc_number] => 20070031422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Selection of cells expressing heteromeric polypeptides' [patent_app_type] => utility [patent_app_number] => 11/544125 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8322 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031422.pdf [firstpage_image] =>[orig_patent_app_number] => 11544125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022122 [patent_doc_number] => 20070148088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Cytotoxic therapy' [patent_app_type] => utility [patent_app_number] => 11/529803 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148088.pdf [firstpage_image] =>[orig_patent_app_number] => 11529803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259636 [patent_doc_number] => 20070213268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/537472 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 45878 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213268.pdf [firstpage_image] =>[orig_patent_app_number] => 11537472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101452 [patent_doc_number] => 07727536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'EG-VEGF nucleic acids and polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/537382 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 77 [patent_no_of_words] => 42890 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727536.pdf [firstpage_image] =>[orig_patent_app_number] => 11537382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7996813 [patent_doc_number] => 08080254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'OB fusion protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/525280 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13431 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 955 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080254.pdf [firstpage_image] =>[orig_patent_app_number] => 11525280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341365 [patent_doc_number] => 07501120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Drug conjugate composition' [patent_app_type] => utility [patent_app_number] => 11/521129 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11073 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501120.pdf [firstpage_image] =>[orig_patent_app_number] => 11521129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634245 [patent_doc_number] => 08012694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Assay for the detection of phosphorylated PTH' [patent_app_type] => utility [patent_app_number] => 11/521007 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 3731 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012694.pdf [firstpage_image] =>[orig_patent_app_number] => 11521007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348536 [patent_doc_number] => 07494649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Drug conjugate composition' [patent_app_type] => utility [patent_app_number] => 11/521120 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11087 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494649.pdf [firstpage_image] =>[orig_patent_app_number] => 11521120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326310 [patent_doc_number] => 07514080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Drug conjugate composition' [patent_app_type] => utility [patent_app_number] => 11/520878 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11069 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514080.pdf [firstpage_image] =>[orig_patent_app_number] => 11520878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278644 [patent_doc_number] => 20090130776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'BINDING PROTEIN MOLECULE' [patent_app_type] => utility [patent_app_number] => 11/995911 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16734 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130776.pdf [firstpage_image] =>[orig_patent_app_number] => 11995911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256077 [patent_doc_number] => 07575745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Ligand for herpes simplex virus entry mediator and methods of use' [patent_app_type] => utility [patent_app_number] => 11/513290 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 37 [patent_no_of_words] => 36918 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575745.pdf [firstpage_image] =>[orig_patent_app_number] => 11513290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360463 [patent_doc_number] => 20090035257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Devices, compositions and methods for the protection and repair of cells and tissues' [patent_app_type] => utility [patent_app_number] => 11/990799 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 29159 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035257.pdf [firstpage_image] =>[orig_patent_app_number] => 11990799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079197 [patent_doc_number] => 20070122421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Innate immune system-directed vaccines' [patent_app_type] => utility [patent_app_number] => 11/507387 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24146 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122421.pdf [firstpage_image] =>[orig_patent_app_number] => 11507387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154341 [patent_doc_number] => 20070037224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Quantitative assays for PDGFR-beta in body fluids' [patent_app_type] => utility [patent_app_number] => 11/502013 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9790 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037224.pdf [firstpage_image] =>[orig_patent_app_number] => 11502013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148734 [patent_doc_number] => 20070048794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use' [patent_app_type] => utility [patent_app_number] => 11/502787 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12002 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048794.pdf [firstpage_image] =>[orig_patent_app_number] => 11502787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106557 [patent_doc_number] => 20070065434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics' [patent_app_type] => utility [patent_app_number] => 11/462983 [patent_app_country] => US [patent_app_date] => 2006-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21980 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065434.pdf [firstpage_image] =>[orig_patent_app_number] => 11462983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106558 [patent_doc_number] => 20070065435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics' [patent_app_type] => utility [patent_app_number] => 11/462984 [patent_app_country] => US [patent_app_date] => 2006-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065435.pdf [firstpage_image] =>[orig_patent_app_number] => 11462984 [rel_patent_id] =>[rel_patent_doc_number] =>)